Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Glutamate Release From Alcohol
NCT04159688Phase 1Completed
- Sponsor
- Yale University
- Start
- Mar 2020
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Yale University. Primary endpoint: Alcohol-induced Change in Receptor Availability at 2 hours. Started Mar 2020; status: completed.
Beyond the preview
Go deeper on NCT04159688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04159688.